Balasa Dinverno & Foltz’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-4,068
| Closed | -$92K | – | 266 |
|
2020
Q1 | $92K | Hold |
4,068
| – | – | 0.01% | 245 |
|
2019
Q4 | $109K | Hold |
4,068
| – | – | 0.01% | 264 |
|
2019
Q3 | $124K | Buy |
4,068
+363
| +10% | +$11.1K | 0.01% | 246 |
|
2019
Q2 | $123K | Buy |
3,705
+223
| +6% | +$7.4K | 0.01% | 238 |
|
2019
Q1 | $218K | Hold |
3,482
| – | – | 0.03% | 229 |
|
2018
Q4 | $87K | Buy |
3,482
+91
| +3% | +$2.27K | 0.01% | 218 |
|
2018
Q3 | $157K | Sell |
3,391
-1,545
| -31% | -$71.5K | 0.02% | 239 |
|
2018
Q2 | $268K | Hold |
4,936
| – | – | 0.04% | 187 |
|
2018
Q1 | $283K | Hold |
4,936
| – | – | 0.04% | 175 |
|
2017
Q4 | $316K | Hold |
4,936
| – | – | 0.05% | 166 |
|
2017
Q3 | $465K | Hold |
4,936
| – | – | 0.07% | 123 |
|
2017
Q2 | $431K | Buy |
4,936
+272
| +6% | +$23.8K | 0.07% | 132 |
|
2017
Q1 | $321K | Buy |
4,664
+273
| +6% | +$18.8K | 0.05% | 151 |
|
2016
Q4 | $316K | Buy |
4,391
+1,000
| +29% | +$72K | 0.05% | 138 |
|
2016
Q3 | $250K | Buy |
3,391
+136
| +4% | +$10K | 0.05% | 153 |
|
2016
Q2 | $271K | Sell |
3,255
-181
| -5% | -$15.1K | 0.05% | 142 |
|
2016
Q1 | $284K | Buy |
3,436
+709
| +26% | +$58.6K | 0.05% | 135 |
|
2015
Q4 | $307K | Buy |
2,727
+18
| +0.7% | +$2.03K | 0.05% | 148 |
|
2015
Q3 | $230K | Buy |
2,709
+1,000
| +59% | +$84.9K | 0.04% | 170 |
|
2015
Q2 | $303K | Sell |
1,709
-46
| -3% | -$8.16K | 0.05% | 142 |
|
2015
Q1 | $211K | Hold |
1,755
| – | – | 0.03% | 190 |
|
2014
Q4 | $198K | Hold |
1,755
| – | – | 0.03% | 189 |
|
2014
Q3 | $176K | Hold |
1,755
| – | – | 0.03% | 178 |
|
2014
Q2 | $231K | Buy |
1,755
+46
| +3% | +$6.06K | 0.03% | 160 |
|
2014
Q1 | $238K | Hold |
1,709
| – | – | 0.03% | 150 |
|
2013
Q4 | $196K | Buy |
1,709
+254
| +17% | +$29.1K | 0.03% | 155 |
|
2013
Q3 | $182K | Buy |
1,455
+137
| +10% | +$17.1K | 0.03% | 143 |
|
2013
Q2 | $52K | Buy |
+1,318
| New | +$52K | 0.01% | 132 |
|